Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JIANGSU MPZ meplazumab study in uncomplicated falciparum malaria
PACTR202310786332004Phase 2Recruiting
- Sponsor
- Jiangsu Pacific Meinuoke Biopharmaceutical
- Start
- Nov 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
Phase 2 trial of meplazumab in Malaria, sponsored by Jiangsu Pacific Meinuoke Biopharmaceutical. Started Nov 2023; status: recruiting.
02
Drugs
meplazumab
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR202310786332004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202310786332004.